Vanda Pharmaceuticals (VNDA) Cash from Investing Activities Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 209.72% |
| Dec 31, 2025 | 36.21% |
| Sep 30, 2025 | 19.59% |
| Jun 30, 2025 | -49.98% |
| Mar 31, 2025 | 16.68% |
| Dec 31, 2024 | 21.44% |
| Sep 30, 2024 | 23.47% |
| Jun 30, 2024 | -5.36% |
| Mar 31, 2024 | 12.95% |
| Dec 31, 2023 | -22.60% |
| Sep 30, 2023 | 42.94% |
| Jun 30, 2023 | -13.52% |
| Mar 31, 2023 | 62.93% |
| Dec 31, 2022 | 59.26% |
| Sep 30, 2022 | -43.24% |
| Jun 30, 2022 | -20.15% |
| Mar 31, 2022 | 21.36% |
| Dec 31, 2021 | -39.04% |
| Sep 30, 2021 | -55.20% |
| Jun 30, 2021 | -20.78% |
| Mar 31, 2021 | 14.98% |
| Dec 31, 2020 | -42.03% |
| Sep 30, 2020 | -179.80% |
| Jun 30, 2020 | -0.74% |
| Mar 31, 2020 | 21.10% |
| Dec 31, 2019 | 26.23% |
| Sep 30, 2019 | -34.66% |
| Jun 30, 2019 | -25.66% |
| Mar 31, 2019 | -148.99% |
| Dec 31, 2018 | 24.80% |
| Sep 30, 2018 | -317.74% |
| Jun 30, 2018 | -155.31% |
| Mar 31, 2018 | -11.75% |
| Dec 31, 2017 | 42.43% |
| Sep 30, 2017 | -23.25% |
| Jun 30, 2017 | -31.33% |
| Mar 31, 2017 | -21.01% |
| Dec 31, 2016 | -27.26% |
| Sep 30, 2016 | -32.66% |
| Jun 30, 2016 | -42.21% |
| Mar 31, 2016 | -20.56% |
| Dec 31, 2015 | 15.76% |
| Sep 30, 2015 | 62.60% |